Monash University

Embargoed and Restricted Access

Reason: Under embargo until 20 June 2025. After this date a copy can be supplied under Section 51(2) of the Australian Copyright Act 1968 by submitting a document delivery request through your library

A prospective double-blind, randomised, phase 3 study of the efficacy of ketamine for cancer treatment-related oral and pharyngeal mucositis pain

posted on 2024-06-20, 00:32 authored by KHUNTHONG PEECHATANAN
Pain from oral and pharyngeal mucositis is often distressing and can be severe and opioid refractory. Currently, there is a lack of guidance for analgesic agents due to limited evidence. This thesis evaluates subcutaneous ketamine’s efficacy compared to active placebo in managing cancer treatment-related oral and pharyngeal mucositis. The findings suggest that a low-dose, continuous subcutaneous ketamine infusion is effective in treating opioid-refractory moderate to severe oral and pharyngeal mucositis pain from cancer treatment.


Principal supervisor

Peter Poon

Additional supervisor 1

Michael Franco

Year of Award


Department, School or Centre

Medicine - Monash Health

Campus location



Doctor of Philosophy

Degree Type



Faculty of Medicine, Nursing and Health Sciences